In vitro studies demonstrated that genistein induced apoptosis in breast cancer cell lines by targeting cells expressing ER-β, decreasing proliferation, inhibiting HER2 expression, targeting EGFR, PDGFR, IR, Abl, and Fgr, and inhibiting the NF-κB signaling pathway [101]. This evidence concerns the gene NFKB1 and breast cancer.